Skip to content

The effect of PPOS+Clomiphene Citrate protocal for IVF-ET therapy in patients with low basal LH

The effect of PPOS+Clomiphene Citrate protocal for IVF-ET therapy in patients with low basal LH

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014440
Enrollment
Unknown
Registered
2018-01-13
Start date
2018-01-01
Completion date
Unknown
Last updated
2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

PPOS /PPOS+CC:PPOS+ Clomiphene Citrate

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Basal serum LH level<2.27mIU/ml; 2. Age<38 years old; 3. Basal FSH level<10mIU/ml.

Exclusion criteria

Exclusion criteria: 1) Clinical significant systemic disease; 2) Endometriosis; 3) patients documented ovarian failure; 4) Idiopathie hypogonadotropoc hypogonadism; 5) Patients with genital tract tumors; 6) Patients recieve hormone treatments within the previous 3 month period.

Design outcomes

Primary

MeasureTime frame
Oocyte retrieval rate;

Secondary

MeasureTime frame
Number of oocyte retrieved;Embryos frozen;

Countries

China

Contacts

Public ContactXuefeng Lu

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

xuefenglu163@163.com+86 135 6459 7129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 8, 2026